You are here
Drugmakers race to bring new cholesterol drugs to US market
REGENERON Pharmaceuticals Inc and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the US market.
The US Food and Drug Administration (FDA) has until July 24 to make a decision on the companies' application to market
CALL +65 6388 3838 EMAIL firstname.lastname@example.org